TickerFactsScreenerDevelopers

ENANTA PHARMACEUTICALS INC (ENTA) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $88.27M2017: $102.81M2018: $206.62M2019: $205.20M2020: $122.47M2021: $97.07M2022: $86.16M2023: $79.20M2024: $67.64M2025: $65.32M$65.32M
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$65.32M-3.4%
2024$67.64M-14.6%
2023$79.20M-8.1%
2022$86.16M-11.2%
2021$97.07M-20.7%
2020$122.47M-40.3%
2019$205.20M-0.7%
2018$206.62M+101.0%
2017$102.81M+16.5%
2016$88.27M—